The plummeting demand for Merck & Co.’s HPV vaccine Gardasil in China has forced the New Jersey drugmaker to rework its ...

China was producing copies of U.S. drugs, but with a big lag time. Armed with the ambition to change that and ample industry experience, she launched a biotech company in 2012 with two former Crown ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations, as the company temporarily paused shipments of a key vaccine into China. Stream Los Angeles News ...

Merck (NSE:PROR) & Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in ...

AI and genetics are creating a 'seismic shift' in the pharmaceutical business, experts on Asian Financial Forum panel say Mainland China could become one of the first markets in the world to approve a ...